BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Conditions: Bronchial Asthma Interventions: Drug: Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation); Drug: Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1; Drug: Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2; Drug: Placebo Sponsors: Cipla Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
Bioequivalence Between Albuterol Sulfate Inhalation Aerosol 108mcg Per Actuation and Proair HFA (Albuterol Sulfate) Inhalation Aerosol 90mcg Per Actuation in Healthy Volunteers Under Fasting Conditions
Condition: Healthy Interventions: Drug: Albuterol Sulfate Inhalation Aerosol 108mcg per actuation; Drug: Proair HFA (albuterol sulfate) Inhalation Aerosol 90mcg per actuation Sponsor: Intech Biopharm Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2022 Category: Research Source Type: clinical trials
Pharmacodynamic Bioequivalence Study of Albuterol Sulfate Inhalation Aerosol, 0.09 mg Albuterol Base/ Inhalation
Condition: Bronchial Asthma Interventions: Other: Methacholine Chloride; Drug: Albuterol Sulfate HFA 0.09 mg (Reference); Drug: Albuterol Sulfate HFA 0.18 mg (Reference); Drug: Albuterol Sulfate HFA 0.09 mg (Test); Drug: Albuterol Sulfate HFA 0.18 mg (Test); Drug: Placebo Sponsor: Aurobindo Pharma Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 23, 2022 Category: Research Source Type: clinical trials
